• +1 700 888 1234

  • Effingerstrasse 40 3008 Bern Switzerland

Press Release: High risk of financial vulnerability after diagnosis: The majority of people impacted by lung cancer experience higher costs and reduction in income

Financial impact of lung cancer: A European perspective High risk of financial vulnerability after diagnosis:  The majority of people impacted […]

8th LuCE Report on Lung Cancer: Launch Event

Join us at our launch of the 8th LuCE report: “Financial impact on lung cancer: A European Perspective”

LuCE attending the European Medicines Agency (EMA) in Amsterdam

November 14th – 15th in Amsterdam We are delighted to announce that Lung Cancer Europe (LuCE) is participating in a two-day meeting […]

Best Advocacy Initiative: Athena.Women Against Cancer

During our Members Meeting 2023, 11 members presented their advocacy initiatives where they shared their goals, projects and accomplishments. With […]

Members Meeting 2023 in Lisbon: Where ideas were generated!

Friday, 29th &  Saturday, 30th September in Lisbon The members of LuCE came together for a highly productive and interactive […]

Workshop on “Knowledge on Artificial Intelligence applied to treatments decision-making”

As a member of the Horizon I3Lung project, Lung Cancer Europe (LuCE) will hold a workshop to explore the knowledge and trust on Artificial Intelligence (AI) of people impacted by lung cancer across Europe. Deadline to apply is June 15th, 2023.